Cuomo: NY will see lower allocation of Johnson & Johnson COVID-19 vaccine next week

Created: April 09, 2021 04:34 PM

ROCHESTER, N.Y. (WHEC) — New York's allocation of Johnson & Johnson COVID-19 vaccine doses will be lower next week.

Gov. Andrew Cuomo Friday said it's a nationwide issue because millions of doses of the Johnson & Johnson vaccine made at the Emergent BioSolutions plant in Baltimore failed a quality check at the end of March.

Johnson & Johnson is now in charge of overseeing that plant, but the impact is unavoidable. 

The governor released the following statement on the situation Friday afternoon:

"Vaccines are the weapon that will win the war against COVID, and with over 11 million shots in arms - including 1.4 million doses administered in just the last seven days - New York's vast distribution network is firing on all cylinders. As has been the case since the beginning of our vaccination effort, the X-factor is supply, supply, supply, and like every other state, our allocation of Johnson & Johnson doses will be significantly lower next week. 
"In Week 18, New York will receive just 34,900 Johnson & Johnson shots - a drop of 88% week-over-week and the first decrease in weeks - while no appointments should have to be cancelled, we will not be able to get as many shots into New Yorkers' arms as we would like. We hope the production issues are resolved as soon as possible, and that production ramps up quickly so we can expand the number of New Yorkers who are vaccinated. In the meantime, we thank the Biden Administration for their herculean efforts to vaccinate all Americans, and look forward to continuing our partnership to stamp out COVID once and for all. As we continue to roll out vaccines, everyone must remember to wear masks, socially distance, wash their hands, and stay New York Tough."

Copyright 2021 - WHEC-TV, LLC A Hubbard Broadcasting Company